Eledon Pharmaceuticals, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Eledon Pharmaceuticals, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Debt Due Cover Ratio: Operating cash was negative last year, while some debt falls due within a year. Lower than 90% of Healthcare companies in United States.
- Steadiness Ratio: Sales grew in 0 of the last 3 years; profit grew in 1 of 3. Less steady than 86% of Healthcare companies in United States.
- Shareholder Slice Ratio: Share count rose 448% in 3 years, so each share's slice of the company became smaller. Bigger rise in share count than 85% of Healthcare companies in United States.
Cash quality
Profit Cash Ratio
—Data incomplete
Self-Funding Ratio
—Data incomplete
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
0/3 · 1/3Sales grew in 0 of the last 3 years; profit grew in 1 of 3.
Less steady than 86% of Healthcare companies in United States.
Growth Efficiency Ratio
—Data incomplete
Asset Productivity Ratio
—Data incomplete
Balance-sheet strength
Debt Due Cover Ratio
-174.1×Operating cash was negative last year, while some debt falls due within a year.
Lower than 90% of Healthcare companies in United States.
Cash Cushion Ratio
+71%Cash, after subtracting all debt, equals 71% of its market value (net cash).
Higher than 83% of Healthcare companies in United States.
Tangible Assets Ratio
81%Of every $100 the company owns, $81 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 51% of Healthcare companies in United States.
Tangible Net Worth Ratio
60%Of every $100 of net worth, $60 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 52% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (10)
Eledon Pharmaceuticals, Inc. made a loss over the last year. Eledon Pharmaceuticals, Inc. owes $0.74 for every $1 it owns. Eledon Pharmaceuticals, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossEledon Pharmaceuticals, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
5.66The share price is 5.66 times Eledon Pharmaceuticals, Inc.'s book value per share, higher than 75% of Healthcare companies in United States.
Market cap
$187 MThe total market value of all of Eledon Pharmaceuticals, Inc.'s shares at today's price (share price × number of shares), smaller than 58% of Healthcare companies in United States. PosiCap size class: Mini Cap.
Net worth (book value)
$33 MWhat Eledon Pharmaceuticals, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$0.41Net worth divided by the number of shares. The share price of $2.30 is 5.7 times this, which is the P/B above.
Return on equity (ROE)
-110.7%Eledon Pharmaceuticals, Inc. lost 110.7% of its shareholders' money over the last year, lower than 73% of Healthcare companies in United States.
Owes vs Owns
0.74×Eledon Pharmaceuticals, Inc. owes $0.74 for every $1 it owns (moderate), higher than 74% of Healthcare companies in United States.
Dividend yield
NoneEledon Pharmaceuticals, Inc. does not currently pay a dividend.
Profit growth
LossEledon Pharmaceuticals, Inc. made a loss in each of the last two years.
Cash vs debt
Net cashEledon Pharmaceuticals, Inc. held $133 M more cash than debt (net cash) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Eledon Pharmaceuticals, Inc.: $187 M ÷ $33 M (30 Jun 2026) = 5.7.
What is Eledon Pharmaceuticals, Inc.'s return on equity?
Eledon Pharmaceuticals, Inc. lost 110.7% of its shareholders' money over the last year, lower than 73% of Healthcare companies in United States.
How much does Eledon Pharmaceuticals, Inc. owe compared with what it owns?
Eledon Pharmaceuticals, Inc. owes $0.74 for every $1 it owns (moderate), higher than 74% of Healthcare companies in United States.
Does Eledon Pharmaceuticals, Inc. pay a dividend?
No. Eledon Pharmaceuticals, Inc. does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.